These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 2948387

  • 21. Effects on blood lipid and androgen levels of two triphasic oral contraceptives.
    Janaud A, Rouffy J, Upmalis D, Dain MP.
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():114-6. PubMed ID: 8260968
    [No Abstract] [Full Text] [Related]

  • 22. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM, Mills RJ.
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [Abstract] [Full Text] [Related]

  • 23. Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration.
    Granger LR, Roy S, Mishell DR.
    Am J Obstet Gynecol; 1982 Nov 01; 144(5):578-84. PubMed ID: 6890312
    [Abstract] [Full Text] [Related]

  • 24. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
    Lepot MR, Gaspard UJ.
    Int J Fertil; 1987 Nov 01; 32 Suppl():15-20. PubMed ID: 2906343
    [Abstract] [Full Text] [Related]

  • 25. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J, Daly L, Carroll E.
    Int J Fertil; 1987 Nov 01; 32 Suppl():21-8. PubMed ID: 2906344
    [Abstract] [Full Text] [Related]

  • 26. Oral contraceptives and blood coagulation.
    Bonnar J, Sabra AM.
    J Reprod Med; 1986 Jun 01; 31(6 Suppl):551-6. PubMed ID: 2941571
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
    Jung-Hoffman C, Kuhl H.
    Am J Obstet Gynecol; 1990 Dec 01; 163(6 Pt 2):2183-97. PubMed ID: 2147819
    [Abstract] [Full Text] [Related]

  • 28. Effects of two oral contraceptive combinations, 0.125 mg desogestrel + 0.050 mg ethinylestradiol and 0.125 mg levonorgestrel + 0.050 mg ethinylestradiol on the adrenal function of healthy female volunteers.
    Ruokonen A, Lund L, Nummi S, Alapiessa U, Viinikka L.
    Eur J Obstet Gynecol Reprod Biol; 1982 Jun 01; 13(4):259-65. PubMed ID: 6214438
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. New progestogens in oral contraceptives.
    Runnebaum B, Rabe T.
    Am J Obstet Gynecol; 1987 Oct 01; 157(4 Pt 2):1059-63. PubMed ID: 2960242
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Contraceptives containing desogestrel or levonorgestrel have different effects on serum lipoproteins and post-heparin plasma lipase activities.
    Kauppinen-Mäkelin R, Kuusi T, Ylikorkala O, Tikkanen MJ.
    Clin Endocrinol (Oxf); 1992 Feb 01; 36(2):203-9. PubMed ID: 1533186
    [Abstract] [Full Text] [Related]

  • 34. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A, Dewailly SD, Grenier R, Huard J.
    J Clin Endocrinol Metab; 1990 Jul 01; 71(1):8-14. PubMed ID: 2142494
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance.
    Kuhl H, Gahn G, Romberg G, Althoff PH, Taubert HD.
    Contraception; 1985 Jul 01; 32(1):97-107. PubMed ID: 2932299
    [Abstract] [Full Text] [Related]

  • 37. Metabolic changes during treatment with two different progestogens.
    Refn H, Kjaer A, Lebech AM, Borggaard B, Schierup L, Bremmelgaard A.
    Am J Obstet Gynecol; 1990 Jul 01; 163(1 Pt 2):374-7. PubMed ID: 2115298
    [Abstract] [Full Text] [Related]

  • 38. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Jul 01; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 39. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
    Jung-Hoffmann C, Fitzner M, Kuhl H.
    Horm Res; 1991 Jul 01; 36(5-6):238-46. PubMed ID: 1823082
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.